Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shoshana Klein

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Molecular Aspects of Medicine|May 11, 2010
Signal transduction therapy of cancerAlexander Levitzki, Shoshana Klein
Chembiochem : a European Journal of Chemical Biology|September 5, 2002
G-protein subunit dissociation is not an integral part of G-protein actionAlexander Levitzki, Shoshana Klein
Advances in Cancer Research|April 11, 2007
Targeted cancer therapy: promise and realityShoshana Klein, Alexander Levitzki
Current Opinion in Cell Biology|February 14, 2009
Targeting the EGFR and the PKB pathway in cancerShoshana Klein, Alexander Levitzki
Proceedings of the National Academy of Sciences of the United States of America|May 12, 2019
My journey from tyrosine phosphorylation inhibitors to targeted immune therapy as strategies to combat cancerAlexander Levitzki, Shoshana Klein
Nature Reviews. Cancer|June 21, 2005
Killing time for cancer cellsShoshana Klein, Frank McCormick, Alexander Levitzki
European Journal of Biochemistry|June 26, 2003
The inhibition of Ras farnesylation leads to an increase in p27Kip1 and G1 cell cycle arrestHadas Reuveni, Shoshana Klein, Alexander Levitzki
Seminars in Cancer Biology|June 29, 2004
RNA molecules as anti-cancer agentsInbar Friedrich, Alexei Shir, Shoshana Klein, et al.
Molecular Biosystems|February 26, 2011
Contribution of gross chromosomal changes to HPV16-induced transformationNataly Kravchenko-Balasha, Shoshana Klein, Myriam Safrai, et al.
Plos One|March 26, 2013
Heterogeneity of gene expression in murine squamous cell carcinoma development-the same tumor by different meansNoam Cohen, Nataly Kravchenko-Balasha, Shoshana Klein, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Molecular Aspects of Medicine|May 11, 2010
Signal transduction therapy of cancerAlexander Levitzki, Shoshana Klein
Chembiochem : a European Journal of Chemical Biology|September 5, 2002
G-protein subunit dissociation is not an integral part of G-protein actionAlexander Levitzki, Shoshana Klein
Advances in Cancer Research|April 11, 2007
Targeted cancer therapy: promise and realityShoshana Klein, Alexander Levitzki
Current Opinion in Cell Biology|February 14, 2009
Targeting the EGFR and the PKB pathway in cancerShoshana Klein, Alexander Levitzki
Proceedings of the National Academy of Sciences of the United States of America|May 12, 2019
My journey from tyrosine phosphorylation inhibitors to targeted immune therapy as strategies to combat cancerAlexander Levitzki, Shoshana Klein
Nature Reviews. Cancer|June 21, 2005
Killing time for cancer cellsShoshana Klein, Frank McCormick, Alexander Levitzki
European Journal of Biochemistry|June 26, 2003
The inhibition of Ras farnesylation leads to an increase in p27Kip1 and G1 cell cycle arrestHadas Reuveni, Shoshana Klein, Alexander Levitzki
Seminars in Cancer Biology|June 29, 2004
RNA molecules as anti-cancer agentsInbar Friedrich, Alexei Shir, Shoshana Klein, et al.
Molecular Biosystems|February 26, 2011
Contribution of gross chromosomal changes to HPV16-induced transformationNataly Kravchenko-Balasha, Shoshana Klein, Myriam Safrai, et al.
Plos One|March 26, 2013
Heterogeneity of gene expression in murine squamous cell carcinoma development-the same tumor by different meansNoam Cohen, Nataly Kravchenko-Balasha, Shoshana Klein, et al.
Pageof 4